Glossary

Sarcopenia

Updated April 9, 2026

Sarcopenia is the age-related loss of muscle strength and muscle quantity, with the strength loss now treated as the key first signal. It matters because the cost is not cosmetic. Lower strength raises fall risk, reduces daily function, and makes illness, dieting, and inactivity hit harder, which is why DEXA Scan for Body Composition and the Leucine Threshold guide both matter more with age than many people expect. A person can keep scale weight stable and still lose muscle in ways that hurt function.

How the term is diagnosed now

The 2019 EWGSOP2 consensus changed the working model. Low muscle strength is now the main entry point. Low muscle quantity or quality confirms the diagnosis. Poor physical performance marks severe sarcopenia.¹

That change is useful because strength usually falls before a scan becomes alarming. The person who needs help often shows up first as weaker, slower, and harder to recover, not as lighter on the scale.

EWGSOP2 commonly uses handgrip strength below 27 kg for men and below 16 kg for women as low, and a chair-stand time above 15 seconds for five rises as poor lower-body function.¹ For appendicular skeletal muscle mass by DXA, rough cut points often used are below 7.0 kg/m² for men and below 5.5 kg/m² for women.¹

Why it develops

Age is part of the story, though it is rarely the whole story. Sarcopenia builds faster when age is combined with low activity, illness, repeated dieting, low protein intake, and anabolic resistance. The body becomes less responsive to a weak protein meal, and inactivity compounds the problem by removing the training stimulus that helps muscle stay worth keeping.

That is why lean mass, protein distribution, and leucine sit close to this topic. Sarcopenia is a meal-structure and movement problem as much as a scan problem.

What the research says

The diagnosis side is now strongly standardized by EWGSOP2.¹ The nutrition and training side is also fairly clear. Komar and colleagues pooled 17 randomized trials and found that leucine supplementation improved sarcopenia-related measures in older adults, which supports the idea that older muscle often needs a stronger amino-acid trigger than younger muscle.² That does not mean free leucine is the first tool. It means the meal-level trigger matters.

Resistance training remains the main intervention. Reviews of sarcopenia treatment consistently find that strength training improves muscle strength and physical function more reliably than supplements alone. Protein helps more when it rides on top of training than when it tries to replace training.

What to do in practice

The most useful plan is simple and repeatable.

The structure matters because sarcopenia is often quiet at first. Breakfast becomes too small. Steps drop. Time out of training gets longer after every interruption. By the time the person notices weakness, months of drift may already be behind them.

Where the condition gets missed

Sarcopenia often gets treated as a word for extreme frailty only. The earlier stage matters more because it is easier to correct, and that earlier stage often looks like weaker lifts, slower chair stands, and poorer recovery rather than obvious disability.

Body weight also hides too much. Stable body weight can mask a swap between fat and muscle that moves strength and function in the wrong direction, which is why lean mass and performance measures usually tell the story sooner than the scale.

Protein powder and creatine can help, though they are not the center of the fix. Progressive resistance training plus enough total protein still drives most of the result.

The useful next reads are anabolic resistance, protein distribution, leucine, and lean mass, because sarcopenia usually starts as a pattern of weaker meals and weaker training before it becomes a formal diagnosis.